drugset / Trial / NCT00419302

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

NCT00419302 ↗

Phase 2 Completed 16 enrolled Mannkind Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This trial was designed to compare meal related inhalation of Technosphere/Insulin to subcutaneous regular insulin in patients with type 2 diabetes.

Timeline

Start
2003-10
Primary completion
—
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Technosphere/Insulin Unknown — Inhaled